510(k) Report

510(k) · Cleared

Cleared

exGraft, exGraft Carbon

K221628510(k) TraditionalCleared Aug 4, 202259-day reviewClass II21 CFR 870.3450

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Peca Labs · DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Cleared on Aug 4, 2022 as substantially equivalent to K202471 (Peca Labs, 2020) after a 59-day review. Its family tree reaches back 2 generations to 2001. 1 later device descends from it.

Decided
Aug 4, 2022
Review
59 days
Class
Class II
Product code
DSY
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K013250 (2001). 1 later device descends from it, 1 citing it directly.

  1. Root · 2 generations backK013250 Gore-Tex Vascular Graft; Gore-Tex Stretch Vascular GraftW. L. Gore & Associates, Inc. · 2001
  2. 1 generation backK202471 exGraft ePTFE Vascular Graft, exGraft Carbon ePTFE Vascular GraftPeca Labs · 2020
  3. This deviceK221628 exGraft, exGraft CarbonPeca Labs · 2022
  4. Descendant · cites it directly · 0 of its ownK233783 exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular GraftsPeca Labs, Inc. · 2024

Most influential descendants

Showing 1 of 1 · See all
  • K233783exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular GraftsPeca Labs, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K013250Gore-Tex Vascular Graft; Gore-Tex Stretch Vascular GraftW. L. Gore & Associates, Inc.2001—
−1K202471exGraft ePTFE Vascular Graft, exGraft Carbon ePTFE Vascular GraftPeca Labs2020—
0 (this device)K221628exGraft, exGraft CarbonPeca Labs2022—
+1K233783exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular GraftsPeca Labs, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K221628, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSY device

  1. #1 K252445 Fusion Bioline Vascular Graftscore 12.4 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K202471exGraft ePTFE Vascular Graft, exGraft Carbon ePTFE Vascular Graft
Summary page 4
…ter Regulatory Class: Class II Product Code: DSY III. PREDICATE DEVICE exGraft and exGraft Carbon ePTFE Vascular Grafts [K202471] Impra Carboflo ePTFE Vascular Grafts [K004012 and K004011], Impra ePTFE Vascular Grafts [K954582 and K830543] are…
Peca Labs2020—
†K004012Impra Carboflo Eptfe Vascular GraftsImpra, Inc.2001—
†K004011Impra Carboflo Vascular Graft, Impra Carboflo Vascular Grafts for a-V AccessImpra, Inc.2001—
†K954582Bard Expanded Ptfe Vascular Graft (Modification)C.R. Bard, Inc.1995—
†K830543Vascular Graft Prosthesis Expanded MicrImpra, Inc.1983—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K233783exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular GraftsPeca Labs, Inc.20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 2 companies; a new generation was cleared every 19.1 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K233783 (Peca Labs, Inc., 2024) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DSY devices

DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · DSY

2in 2025

2007: 12008: 12009: 52010: 42011: 12012: 42013: 52014: 22015: 12016: 12017: 32018: 12019: 12020: 12021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 5 (2009) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSY

160in 2024

2009: 73 days median2010: 55 days median2012: 30 days median2013: 69 days median2017: 269 days median2024: 160 days median
2007high 269 (2017) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSY

1in 2025

2009: 22010: 52013: 12016: 22025: 12026 (partial year): 1
2007high 5 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSY

151in 2025

2007: 1202008: 1642009: 1932010: 1872011: 1652012: 1772013: 2072014: 3522015: 4602016: 2172017: 1932018: 2002019: 2322020: 1692021: 1682022: 1552023: 1492024: 1532025: 151
2007high 460 (2015) · low 120 (2007)2025

MAUDE reports naming product code DSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0120
20081—0164
20095732193
20104555187
20111—0165
20124300177
20135691207
20142—0352
20151—0460
20161—2217
201732690193
20181—0200
20191—0232
20201—0169
20212—0168
20222—0155
20232—0149
202451600153
20252—1151
20261—1—

What is it indicated for?

The exGraft and exGraft Carbon ePTFE Vascular Grafts are indicated for use as vascular prostheses.

exGraft and exGraft Carbon ePTFE Vascular Grafts are intended for use as vascular prostheses for replacement or bypass of diseased vessels in patients suffering occlusive or aneurysmal diseases, in trauma patients requiring vascular replacement, for dialysis access, or for other vascular procedures,

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K221628: exGraft, exGraft Carbon.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K221628

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026